Hyperlactatemia During and After Tumorcraniotomy
Status
Conditions
Treatments
Details and patient eligibility
About
This study aims to investigate the association between hyperlactatemia and neurological disability, length-of-stay and mortality in patients who undergo tumorcraniotomy. The risk factors that induce lactat accumulation will also be explored.
Full description
Hyperlactatemia is a frequent occurrence in brain tumor surgery. The existing studies, however, are all retrospective, reporting varying effects on clinical outcome. One study reported new neurological deficitis, some found an association with extended hospital stay, while others found no association with outcome. It is therefore important to conduct a prospective study of hyperlactatemia in this patientgroup.
Participants in this study will follow the standard treatment protocol for tumorcraniotomy, aside from 2-3 additional, perioperative blodgas analyses and 2 standardized measurements of neurological disability.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Age >/= 18 years
- Must undergo elective tumor craniotomy
- Understand oral and written Danish
Exclusion criteria
- Adults with incapacity
- Stereotactic biopsy
- Lack of informed and signed consent to participate in study
Trial design
450 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal